175 related articles for article (PubMed ID: 12024319)
1. Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog.
Weiss DJ; Aird B
Vet Clin Pathol; 2001; 30(2):67-75. PubMed ID: 12024319
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Primary myelodysplastic syndromes of dogs: a report of 12 cases.
Weiss DJ; Smith SA
J Vet Intern Med; 2000; 14(5):491-4. PubMed ID: 11012110
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome with sideroblastic differentiation in a dog.
Weiss DJ; Lulich J
Vet Clin Pathol; 1999; 28(2):59-63. PubMed ID: 12075526
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
6. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
7. New insights into the physiology and treatment of acquired myelodysplastic syndromes and aplastic pancytopenia.
Weiss DJ
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1317-34. PubMed ID: 14664201
[TBL] [Abstract][Full Text] [Related]
8. Myelopoiesis and myeloproliferative disorders.
Raskin RE
Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1023-42. PubMed ID: 8863389
[TBL] [Abstract][Full Text] [Related]
9. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
10. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
11. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
12. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
Polychronopoulou S; Panagiotou JP; Kossiva L; Mavrou A; Anagnostou D; Haidas S
Acta Paediatr; 2004 Aug; 93(8):1015-23. PubMed ID: 15456186
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
Bennett JM
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
[TBL] [Abstract][Full Text] [Related]
15. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
16. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
Senent L; Arenillas L; Luño E; Ruiz JC; Sanz G; Florensa L
Haematologica; 2013 Apr; 98(4):568-75. PubMed ID: 23065505
[TBL] [Abstract][Full Text] [Related]
18. [Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia].
Gu LL; Kang HY; Pan YL; Liu GX; Ge SJ; Li MY; Wang CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):138-43. PubMed ID: 26913410
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
20. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
